Sequential first and second trimester ultrasound screening for early detection of fetal anomalies: a prospective observational study

Authors

  • Savan Aghara Department of Obstetrics and Gynaecology, NHL Medical College, Ahmedabad, Gujarat, India
  • Swati Rankja Department of Community Medicine, GMERS Medical College and General Hospital, Gujarat, India
  • Jayun Joshi Department of Obstetrics and Gynaecology, NHL Medical College, Ahmedabad, Gujarat, India
  • Dharmi Rankja MBBS Graduate, Parul Institute of Medical Science and Research, Gujarat, India
  • Dhruvi Rankja MBBS Graduate, Shantaba Medical College, Gujarat, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20261602

Keywords:

Prenatal screening, Fetal abnormalities, First trimester ultrasonography, Second trimester ultrasound, Congenital anomalies

Abstract

Background: First-trimester ultrasonography at 11–13⁺⁶ weeks plays a vital role in early detection of chromosomal abnormalities and structural fetal anomalies. When combined with a second-trimester anomaly scan at 18–24 weeks, it enhances diagnostic accuracy and improves pregnancy management.

Methods: This prospective observational study was conducted at a tertiary care centre from January 2023 to January 2025 and included. The expected prevalence of fetal anomalies (3–5%) and, this sample size 220 randomly selected singleton antenatal women between 11–13⁺⁶ weeks of gestation was considered adequate to assess the detection rate with reasonable accuracy. First-trimester evaluation included nuchal translucency (NT), nasal bone, ductus venosus Doppler, tricuspid regurgitation, and early fetal anatomical survey. All participants subsequently underwent a detailed anomaly scan at 18–24 weeks.

Results: This prospective observational study included 220 singleton antenatal women who underwent sequential ultrasound screening at 11–13⁺⁶ weeks and 18–24 weeks of gestation. A total of 11 foetuses (5%) were diagnosed with anomalies, of which 10 cases (4.55%) were detected during the first-trimester scan and 1 case (0.45%) during the second-trimester scan. Detected anomalies included chromosomal abnormalities (Trisomy 21,18, and 13), increased nuchal translucency, and structural defects involving the central nervous system, cardiac system, abdominal wall, and genitourinary system. Increased NT (>95th percentile) was observed in 6.4% cases. Anomalies were slightly more common in multigravida women and referred cases.

Conclusions: In the present study, sequential first and second trimester ultrasound screening proved effective in early detection of fetal anomalies, enabling timely counselling and appropriate pregnancy management.

References

WHO. Birth defects (congenital disorders). Geneva: World Health Organization. 2023. Available at: https://www.who.int/news-room/fact-sheets/detail/birth-defects/. Accessed on 18 February 2026.

Cunningham FG, Leveno KJ, Dashe JS, Hoffman BL, Spong CY, Casey BM. Obstetrics. 26th ed. New York: McGraw-Hill. 2022;749-54.

Rumack CM, Levine D. Diagnostic ultrasound. 5th ed. Philadelphia (PA): Elsevier. 2018.

Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn. 2011;31:7-15.

Souka AP, Snijders RJM, Novakov A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10–14 weeks of gestation. Ultrasound Obstet Gynecol. 1998;11:391-400.

Maiz N, Valencia C, Kagan KO, Wright D, Nicolaides KH. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestation. Ultrasound Obstet Gynecol. 2009;33:512-7.

Syngelaki A, Hammami A, Bower S, Zidere V, Akolekar R, Nicolaides KH. Diagnosis of fetal non-chromosomal abnormalities on routine ultrasound examination at 11–13 weeks’ gestation. Ultrasound Obstet Gynecol. 2019;54:468-76.

Salomon LJ, Alfirevic Z, Berghella V, Bilardo CM, Hernandez-Andrade E, Johnsen SL, et al. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2011;37:116-26.

International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). Performance of the routine mid-trimester fetal ultrasound scan. ISUOG; 2022. Available at: https://www.isuog.org/resource/isuog-practice-guidelines-updated-performance-of-the-routine-mid-trimester-fetal-ultrasound-scan.html. Accessed on 18 February 2026.

Liao YM, Li SL, Luo GY, Wen HX, Ouyang SY, Chen CY, et al. Routine screening for fetal limb abnormalities in the first trimester. Prenat Diagn. 2016;36(2):117-26.

Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med. 2005;353:2001-11.

Chervenak FA, McCullough LB, Levene MI. An ethically justified, clinically comprehensive approach to peri-viability: gynaecological, obstetric, perinatal and neonatal dimensions. J Obstet Gynaecol. 2007;27:3-7.

Grandjean H, Larroque D, Levi S. Sensitivity of routine ultrasound screening of pregnancies in the Eurofetus database. Ann N Y Acad Sci. 1998;847:118-24.

Whitworth M, Bricker L, Mullan C. Ultrasound for fetal assessment in early pregnancy. Cochrane Database Syst Rev. 2015;(7):CD007058.

Souka AP, Pilalis A, Kavalakis I, Papantoniou N, Mesogitis S, Dalkalitsis N. Screening for major structural abnormalities at the 11- to 14-week ultrasound scan. Am J Obstet Gynecol. 2006;194:393-6.

Syngelaki A, Hammami A, Bower S, Zidere V, Akolekar R, Nicolaides KH. Diagnosis of fetal non-chromosomal abnormalities on routine ultrasound examination at 11–13 weeks’ gestation. Ultrasound Obstet Gynecol. 2019;54:468-76.

Becker R, Wegner RD. Detailed screening for fetal anomalies and cardiac defects at the 11–13-week scan. Ultrasound Obstet Gynecol. 2006;27:613-8.

Grande M, Arigita M, Borobio V, Jiménez JM, Fernández S, Borrell A. First-trimester detection of structural abnormalities and the role of aneuploidy markers. Ultrasound Obstet Gynecol. 2012;39:157-63.

Viora E, Zamboni C, Mortara G, Stillavato S, Bastonero S, Errante G, et al. Trisomy 18: fetal ultrasound findings at different gestational ages. Am J Med Genet A. 2007;143A:553-7.

Boyd PA, Devigan C, Khoshnood B, Loane M, Garne E, Dolk H, et al. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down’s syndrome. BJOG. 2008;115:689-96.

Borrell A, Grande M, Pauta M, Rodríguez-Revenga L, Figueras F. Chromosomal microarray analysis in fetuses with growth restriction and normal karyotype: a systematic review and meta-analysis. Fetal Diagn Ther. 2018;44:1-9.

Carvalho JS, Moscoso G, Tekay A, Campbell S, Thilaganathan B, Shinebourne EA. Clinical impact of first and early second trimester fetal echocardiography on high-risk pregnancies. Heart. 2004;90:921-6.

Parisi N, Rizzo G, Cecchini F, Schiattarella A, Khalil A, Mappa I, et al. Outcome of apparently isolated fetal posterior fossa anomalies: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2025;66:571-81.

Rossi AC, Prefumo F. Accuracy of ultrasonography at 11–14 weeks of gestation for detection of fetal structural anomalies: a systematic review. Obstet Gynecol. 2013;122:1160-7.

Downloads

Published

2026-05-28

How to Cite

Aghara, S., Rankja, S., Joshi, J., Rankja, D., & Rankja, D. (2026). Sequential first and second trimester ultrasound screening for early detection of fetal anomalies: a prospective observational study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 15(6), 2014–2018. https://doi.org/10.18203/2320-1770.ijrcog20261602

Issue

Section

Original Research Articles